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Table 2
study results stratiﬁed fur gender
Characteristics Men with CVD Men without CVD Woman with CVD Woman without CVD
Number (%) 26 (49) 129 (32) 27 (51) 276 (68)
Age, years, mean (SD) 64.77.8 62.37.9 66.19.7 60.1 8.6*
Body mass index, kg/m2 mean (SD) 29.54.9 29.55.6 34.18.3 30.05.9*
Radiographic OA  Kellgren/Lawrence score 2 n (%) 16 (64) 101 (83)* 8 (44) 164 (66)
Total extension left and right knee (Nm/kg), mean (SD) 1.220.44 1.420.49* 0.740.43 9.850.40
Total ﬂexion score left and right knee (Nm/kg), mean (SD) 0.780.24 0.950.29* 0.450.25 0.570.23*
Total ﬂexion and extension score (Nm/kg), mean (SD) 0.960.39 1.180.38* 0.610.35 0.750.47
Proprioceptive accuracy, degrees, left and right knee, median 2.8 (1.9-4.4) 2.2 (1.2-8.3) 3.0 (2.2-4.6) 2.5 (1.6-4.2)
Laxity, degrees, left and right knee, median (IQR) 5.2 (3.6-6.3) 4.3 (3.5-5.7) 8.2 (5.0-10.0) 8.0 (6.2-10.2)
WOMAC physical function score (0-68), mean (SD) 26.012.8 23.212.7 31.513.5 28.812.6
Get up and Go test, seconds, median (IQR) 10.3 (9.6-12.6) 9.7 (8.5-11.4) 16.5 (11.3-20.5) 10.7 (9.3-13.4)
Stairclimb test up, seconds, median (IQR) 6.6 (4.5-7.8) 5.4 (4.3-6.7)* 10.3 (6.7-15.4) 6.8 (5.4-8.9)*
Stairclimb test down, seconds, median (IQR) 7.3 (5.5-9.9) 5.4 (4.3-7.2) 12.1 (7.9-18.7) 7.2 (5.7-9.8)*
ESR, mm/hour, median (IQR) 6 (3-16) 6 (2-11) 14 (8-26) 19 (5-18)
CRP mg/L, median (IQR) 2 (1-3) 2 (1-3) 3 (1-7) 2 (1-4)
Hemoglobulin, mmol/L, median (IQR) 9.2 (8.8-9.7) 9.3 (8.9-9.3) 8.4 (7.8-9.0) 8.6 (8.2-9.9)
Leucocytes, 10e9/L, median (IQR) 7.6 (5.7-8.6) 6.6 (5.6-7 7) 7.5 (6 3-8.9) 6.9 (5.9-7.9)
Thrombocytes, 10e9/L, median (IQR) 240 (211-232) 237 (209-269) 261 (224-399) 266 (226-298)
Creatinin, umol/L, median (IQR) 88 (71-96) 79 (73-37) 67 (61-79) 64 (53-72)
ASAT, U/L, median (IQR) 30 (26-34) 29 (26-34) 28 (25-31) 23 (22-30)
ALAT, U/L, median (IQR) 28 (22-42) 29 (22-39) 25 (19-31) 21 (17-28)
Alkaline phosphatase, U/L, median (IQR) 85 (70-95) 75 (63-93) 94 (81-98) 80 (65-94)*
25-OH-Vitamin D, nmol/L, median (IQR) 62 (38-91) 60 (46-76) 50 (37-60) 60 (43-79)
*Signiﬁcant difference between subgroups (p<0.05) n: number; SD. standard deviation, IQR: interguartile range.
Table 1
Study group results
Characteristics Total population Patients with CVD Patients without CVD
Total number (%) 458 53 (12) 405 (88)
Age, years, mean (SD) 61.29.0 65.48.8 60.78.9*
Body mass index, kg/m2, mean (SD) 30.1+6.0 31.8+7.2 29.9+5.8*
Radiographic OA  Kellgren/Lawrence score 2 n (%) 289 (70) 24 (56) 265 (71)*
Total Extension left and right knee, Nm/kg, mean (SD) 1.040.49 1.010.49 1.050.49
Total ﬂexion score left and right knee, Nm/kg mean (SD) 0.690.31 0.630.29 0.690.31
Total ﬂexion and extension score, Nm/kg, mean (SD) 0.880.48 0.800.41 0.890.49
Proprioceptive accuracy, degrees, left and right knee, mean (SD) 2.5 (1.6-4.1) 2.9 (2.1-4.5) 2.4 (1.5-4.1)
Laxity, degrees, left and right knee, mean (SD) 6.5 (4.5-9.1) 5.8 (4.3-8.0) 6.6(4.6-9.2)
WOMAC physical function score (0-68), mean (SD) 27.213.0 28.813.3 27.012.9
Get up and Go test, seconds, median (IQR) 10.4(9 1- 12.4(9.9-16.8) 10.4 (9.0-12.9)
Stairclimb Time going up, seconds, median (IQR) 6.5 (5.0-8.5) 7.2 (5.9-10.7) 6.4 (5.0-8.2)*
Stairclimb Time going down, seconds, median (IQR) 6.8 (5.2-9.4) 8.6(6.4-13.7) 6.7 (5.1-9.1)*
ESR mm/hour, median (IQR) 9 (4-16) 10 (4-21) 9 (4-16)
CRP, mg/L, median (IQR) 2 (1-4) 2 (1-6) 2 (1-4)
Hemoglobulin, mmol/L, median (IQR) 8.8 (8.4-9.2) 8.9 (8.3-9.5) 8.8 (8.4-9.2)
Leucocytes, 10e9/L, median (IQR) 6.9 (5.9-7.9) 7.5 (6.1-8.6) 6.8 (5.9-7.8)*
Thrombocytes, 10e9/L, median (IQR) 290) 240 (220-288) 255 (218-290)
Creatinin, umol/L, median (IQR) 70 (61-80) 78 (65-93) 70 (60-79)*
ASAT, U/L, median (IQR) 27 (24-32) 28 (26-32) 27(24-31)*
ALAT, U/L, median (IQR) 23 (18-33) 28 (21-36) 23 (18-32)
Alkaline phosphatase, U/L, median (IQR) 79 (65-94) 92 (74-97) 78 (64-94)*
25-OH-Vitamin D, nmol/L, median (IQR) 76 (51-999) 55 (38-82) 60 (44-76)
*Signiﬁcant difference between subgroups (p<0.05); n: number; SD: standard deviation; IQR: interquartile range.
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BEHAVIORAL VARIABLES ARE ASSOCIATED WITH SURGICALLY
INDUCED KNEE OSTEOARTHRITIS IN RATS
C.B. Hamilton, M.A. Pest, V. Pitelka, A. Ratneswaran, F. Beier,
B.M. Chesworth. The Univ. of Western Ontario, London, ON, Canada
Purpose: To determine whether pain-related behavior and variables of
exploratory behavior in rats can be used to distinguish between a sham
surgery and a surgically-induced rat model of early-moderate stage
knee osteoarthritis (OA).
Methods: Two groups of male Sprague-Dawley rats were used, a knee
OA rat model (n¼6) and a sham surgery (n¼5). After 1 week of accli-
matization, the rats’ right knee joint was destabilized by anterior cru-
ciate ligament (ACL) transection and partial medial meniscectomy as
described (Appleton ART 2007). Sham surgery involved only visual-
ization of the ACL. For pain-related behavior, hind limbs weight bearingwas assessed at week one, two, four, six, and eight post-surgery using
an incapacitance tester (Linton, Norfolk, UK). The average weight on
each hind limb over ﬁve second for ﬁve trials was recorded. Exploratory
behavior (18 variables) was assessed for 30 minutes at week four, six,
and eight post-surgery using an Open Field Tester (Omnitech Electronic,
Columbus, Ohio), with cage height ¼ 13.0”, width ¼ 16.5”, and length ¼
16.5”. Exploratory behavior was measured with horizontal, vertical,
revolution and sedentary activities (both counts and duration). Micro-
CT and histology were performed post-mortem at week 8 post-surgery
to conﬁrm knee OA.
First, 2-way repeated measures Analysis of Variance (ANOVA) tested
whether the observed percentageweight bearing on the right hind limb
(a likely indicator for pain) and exploratory behavior (18 different var-
iables) were each signiﬁcantly different between the study groups and
overtime. Second, Pearson correlation coefﬁcients (r) were calculated
between the behavioral variables to evaluate the presence of
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calculated between each exploratory behavior variable and the group
variable. Where collinearity occurred, the variable most correlated with
the group variable was selected for entry into logistic regression. Fourth,
during logistic regression the forward stepwise method was used, eight
exploratory behavior variables were entered as predictors of study
group allocation. Signiﬁcance was tested at two-tailed p < 0.05.
Results: Micro-CT conﬁrmed knee OA in the OA rat model. Weight
bearing had a signiﬁcant main effect by study group (F(1,9)¼24.591 ,
p¼0.001). Percent weight bearing by the right hind limb was sig-
niﬁcantly different between the groups at week two, six, and eight post-
surgery, but not at week four. Exploratory behavior variables showed no
main effect by group, nine variables had a main effect by time, of which
three variables had an interaction effect. Parsing these interaction
effects reveal no signiﬁcant difference in ambulatory episodes between
groups at each time point. The OA rat model had more ambulatory
episodes at week four, which was not statistically signiﬁcant (p ¼
0.062). Vertical episodes were consistently lower for the OA rat model,
but statistically signiﬁcant only at week four. Counter-clockwise revo-
lution was not statistically signiﬁcant between groups at each time
point, but was signiﬁcant by time within the OA group. Logistic
regression revealed weight bearing and only these same three explor-
atory variables (ambulatory episode, vertical episode, and counter-
clockwise revolution) were signiﬁcant predictors of study group status
(see table 1).
Conclusions: This knee OA rat model was symptomatic in terms of
pain-related and exploratory behavior. This study showed that weight
bearing and three exploratory behavior variables may be useful out-
come measures in the preclinical pharmacological studies with this
knee OA rat model. However, evaluation of exploratory behavior for
longer periods would be more consistent with some other studies, and
might increase power to detect statistical signiﬁcance.Association of Exploratory Behavior Variables with study group status
Variable B* P value Sham vs OA modelOdd Ratio
Ambulatory Episode -.171 0.037 0.842
Vertical Episode .109 0.004 1.115
Counter Clockwise Revolution -.218 0.018 0.804
*Negative sign means as counts increased in the knee osteoarthritis group, they
decreased in the sham group.702
ROLE OF PLATELETS IN THE PATHOGENESIS OF OSTEOARTHRITIS
AND BIOLOGICAL EFFECTS OF HYALURONIC ACID: IN VIVO AND IN
VITRO STUDY
A. Alunno y, E. Petito z, N. Giordan x, G. Mirabelli y, E. Falcinelli z,
F. Luccioli y, S. Momi z, E. Bartoloni y, G. Santoboni y, O. Bistoni y,
S. Caterbi y, P. Gresele z, R. Gerli y. yRheumatology Unit Dept. of Clinical
and Experimental Med., University of Perugia, Italy; z Section of Internal
and Vascular Med. Dept. of Internal Med., University of Perugia, Italy;
x Fidia Farmaceutici S.p.A, Abano Terme (PD), Italy
Purpose: Although osteoarthritis (OA) is a degenerative joint disorder,
it has been demonstrated that inﬂammation takes part in the devel-
opment and progression of this condition. Matrix metalloproteinases
(MMPs), including MMP-2, are involved in the cartilage breakdown
observed in OA. Platelets (PLTs) are involved in different inﬂammatory
conditions, including rheumatoid arthritis, contain and release several
MMPs, including MMP-2, and enhance MMPs expression by other cell
types. However, their role in OA has not been investigated yet. Hya-
luronic acid (HA) is a normal component of extracellular matrix and
synovial ﬂuid (SF). Intra-articular (IA) administration of HA in OA is
widely employed in clinical practice with good clinical efﬁcacy. Aims of
our study were to investigate the role of platelets and MMP-2 in the
pathogenesis of OA, to test the biologic activity of IA-HA in OA patients
and to analyze the effects of HA on the interaction between platelets
and synoviocytes in vitro.
Methods: Thirty-eight patients with knee OA were screened and
twenty-four patients were included in the study. Systemic therapy with
non-steroidal anti-inﬂammatory drugs or corticosteroids and previous
IA corticosteroid treatment represented exclusion criteria. Five injec-
tions of IA sodium hyaluronate (500-730 KDa) were administrated
weekly. SF samples were collected prior to the ﬁrst (T0) and at the last(T1) injection. Total cell and PLT count, platelet-leukocyte aggregates
(PLT activation marker) and MMP-2 levels were measured in SF. For
clinical assessment at T0, T1 and 3 months after the last injection (T3)
the Western Ontario and Mc Masters University (WOMAC) scale and
VAS for knee pain were employed.
Fibroblast-like synoviocytes (FLS) were isolated from untreated OA-SF
and cultured with PLTs in presence or absence of HA at different con-
centrations for 24 hours. Platelet P-selectin was measured by ﬂow-
cytometry and MMP-2 in culture supernatants was quantiﬁed by
zymography.
Results: Total cell count in SF was signiﬁcantly reduced after IA-HA
(p<0.05). PLT count, platelet-leukocyte aggregates and MMP-2 con-
centration were signiﬁcantly decreased at T1 (all p<0.05). WOMAC
scale and pain VAS were reduced at T1 (p<0.0001) and this decrease
was maintained at T3. MMP-2 production by FLS was signiﬁcantly
higher in the presence of PLTs and this increase was signiﬁcantly
reduced by co-incubation with HA. P-selectin expression, marker of PLT
activation, was signiﬁcantly higher in PLTs cultured with FLS and P-
selectin blockade reduced MMP-2 release in culture supernatants.
Conclusions: Our results show that PLTs, in addition to other inﬂam-
matory cells, participate in the pathogenesis of OA by the induction of
MMP-2 release by FLS possibly via P-selectin, thus contributing to
cartilage breakdown. Treatment with HA decreases count and activa-
tion of PLT and levels of MMP-2 in the SF. PLT and synoviocytes inter-
action leads to platelet activation and MMP-2 release enhancement.
Hence, PLTs may represent a new therapeutic target in OA.
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REPLICATION STUDY TO IDENTIFY CLINICALLY RELEVANT
PHENOTYPES FROM A KNEE OSTEOARTHRITIS POPULATION: DATA
FROM THE AMSTERDAM OSTEOARTHRITIS COHORT
J. Knoop y, L.D. Roorda y, M. van der Leeden y,z, M. van der Esch y,
D.L. Knol z, W.F. Lems y,z, J. Dekker z. yReade, center for rehabilitation and
rheumatology, Amsterdam, Netherlands; zVU Univ. Med. Ctr., Amsterdam,
Netherlands
Purpose: We previously identiﬁed 5 clinically relevant phenotypes
from a heterogeneous knee OA population (Osteoarthritis Initiative
[OAI] cohort). The present study aims to replicate this phenotype
identiﬁcation for validation in a clinical setting using data from the
Amsterdam Osteoarthritis (AMS-OA) cohort.
Methods: K-means clustering analysis was performed in 374 knee OA
patients from the AMS-OA cohort, using 4 clinically relevant and easily
obtainable patient characteristics or clustering variables: radiographic
severity (Kellgren/Lawrence [K/L]grade), bodymass index (BMI),upper leg
muscle strength, and depression (from Hospital Anxiety and Depression
Scale [HADS] questionnaire). The cluster solutionwith the highest Pseudo
F value was considered the most adequate number of clusters or pheno-
types in the dataset. This solution was compared with the original study.
Results: The most adequate number of phenotypes was 5, similar as in
the original study. Moreover, the 5 identiﬁed phenotypes represented in
general similar phenotypes compared to the original study, namely a
‘minimal joint disease phenotype’, a ‘strong muscle phenotype’, a ‘non-
obese weak muscle phenotype’ (although obesity was more prevalent
compared to the original study), an ‘obeseweakmuscle phenotype’, and
a ‘depressive phenotype’ (although depression was less prevalent
compared to the original study).
Conclusions: The identiﬁcation of phenotypes from the OAI cohort
could be replicated, except for two minor differences that are pre-
sumably attributable to differences in study population. The phenotype
identiﬁcation seems therefore a valid ﬁnding, with phenotypes possibly
representing different etiological subtypes of knee OA in which phe-
notype-speciﬁc interventions may be needed.
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CHANGES IN SERUM C-REACTIVE PROTEIN AND ERYTHROCYTE
SEDIMENTATION RATE DO NOT ASSOCIATE WITH RADIOGRAPHIC
PROGRESSION IN PATIENTS WITH KNEE OSTEOARTHRITIS: A 2
YEAR FOLLOW UP STUDY IN THE AMS-OA COHORT
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yMOVE Res. Inst. Amsterdam. VU Univ., Amsterdam, Netherlands; zKU
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